1. Home
  2. SII vs BVS Comparison

SII vs BVS Comparison

Compare SII & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SII
  • BVS
  • Stock Information
  • Founded
  • SII 2008
  • BVS 2011
  • Country
  • SII Canada
  • BVS United States
  • Employees
  • SII N/A
  • BVS N/A
  • Industry
  • SII Finance: Consumer Services
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SII Finance
  • BVS Health Care
  • Exchange
  • SII Nasdaq
  • BVS Nasdaq
  • Market Cap
  • SII 1.1B
  • BVS 883.7M
  • IPO Year
  • SII N/A
  • BVS 2021
  • Fundamental
  • Price
  • SII $42.87
  • BVS $11.41
  • Analyst Decision
  • SII
  • BVS Strong Buy
  • Analyst Count
  • SII 0
  • BVS 3
  • Target Price
  • SII N/A
  • BVS $15.00
  • AVG Volume (30 Days)
  • SII 89.3K
  • BVS 297.3K
  • Earning Date
  • SII 11-06-2024
  • BVS 11-05-2024
  • Dividend Yield
  • SII 2.79%
  • BVS N/A
  • EPS Growth
  • SII 19.61
  • BVS N/A
  • EPS
  • SII 1.81
  • BVS N/A
  • Revenue
  • SII $194,378,000.00
  • BVS $555,061,000.00
  • Revenue This Year
  • SII $8.22
  • BVS $11.24
  • Revenue Next Year
  • SII $0.44
  • BVS $6.77
  • P/E Ratio
  • SII $23.79
  • BVS N/A
  • Revenue Growth
  • SII 32.38
  • BVS 10.40
  • 52 Week Low
  • SII $31.47
  • BVS $3.90
  • 52 Week High
  • SII $48.00
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • SII 42.07
  • BVS 43.94
  • Support Level
  • SII $43.45
  • BVS $10.95
  • Resistance Level
  • SII $46.22
  • BVS $11.54
  • Average True Range (ATR)
  • SII 0.95
  • BVS 0.48
  • MACD
  • SII -0.12
  • BVS -0.04
  • Stochastic Oscillator
  • SII 1.65
  • BVS 13.84

About SII Sprott Inc.

Sprott Inc is an alternative asset manager operating in Canada. The company has four reportable segments: Exchange Listed Products, which includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the Company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; Corporate segment which provides capital, balance sheet management and enterprise shared services to the Company's subsidiaries.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: